Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Open accessThe DOI matches its Crossref record; 1,028 of the 1,028 references it cites were found in a registry or an index.
Abstract
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary field that is garnering a lot of interest and investigation. Nanomedicine shows great potential for cancer diagnosis and treatment. Specifically engineered nanoparticles can be employed as contrast agents in cancer diagnostics to enable high sensitivity and high-resolution tumor detection by imaging examinations. Novel approaches for tumor labeling and detection are also made possible by the use of nanoprobes and nanobiosensors. The achievement of targeted medication delivery in cancer therapy can be accomplished through the rational design and manufacture of nanodrug carriers. Nanoparticles have the capability to effectively transport medications or gene fragments to tumor tissues via passive or active targeting processes, thus enhancing treatment outcomes while minimizing harm to healthy tissues. Simultaneously, nanoparticles can be employed in the context of radiation sensitization and photothermal therapy to enhance the therapeutic efficacy of malignant tumors. This review presents a literature overview and summary of how nanotechnology is used in the diagnosis and treatment of malignant tumors. According to oncological diseases originating from different systems of the body and combining the pathophysiological features of cancers at different sites, we review the most recent developments in nanotechnology applications. Finally, we briefly discuss the prospects and challenges of nanotechnology in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 801–1,000 of 1,028
Hirche, C. R., Engel, H., Kolios, L., Cognié, J., Hünerbein, M., Lehnhardt, M., & Kremer, T. L. (2012) · Surgical Innovation · doi:10.1177/1553350612468962 · Cited by 60
Fan, H., Zhang, I., Chen, X., Zhang, L., Wang, H., Fonseca, A. D., Manuel, E. R., Diamond, D. J., Raubitschek, A. A., & Badie, B. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1911 · Cited by 60
Self-citationGu, X., Qiu, Y., Lin, M., Cui, K., Chen, G., Chen, Y., Fan, C., Zhang, Y., Xu, L., Chen, H., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01065 · Cited by 60
Update on systemic treatment for newly diagnosed inflammatory breast cancer
Chainitikun, S., Saleem, S., Lim, B., Valero, V., & Ueno, N. T. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.08.014 · Cited by 60
Wang, S., Li, B., Zhang, H., Chen, J., Sun, X., Xu, J. H., Ren, T., Zhang, Y., Ma, C., Guo, W., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101938 · Cited by 60
Self-citationAn engineered influenza virus to deliver antigens for lung cancer vaccination
Ji, D., Zhang, Y., Sun, J., Zhang, B., Ma, W., Cheng, B., Wang, X., Li, Y., Yu, M., Xu, H., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01796-7 · Cited by 60
Wei, J., Cheang, T., Tang, B., Xia, H., Xing, Z.-H., Chen, Z., Fang, Y., Chen, W., Xu, A., Wang, S., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.068 · Cited by 59
A peptide functionalized nanomotor as an efficient cell penetrating tool
Peng, F., Tu, Y., Adhikari, A., Hintzen, J. C. J., Löwik, D. W. P. M., & Wilson, D. A. (2016) · Chemical Communications · doi:10.1039/c6cc09169e · Cited by 59
Ramya, A. N., Joseph, M. M., Maniganda, S., Karunakaran, V., Sreelekha, T. T., & Maiti, K. K. (2017) · Small · doi:10.1002/smll.201700819 · Cited by 59
Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma
Au, K. M., Tripathy, A., Lin, C. P.-I., Wagner, K., Hong, S., Wang, A. Z., & Park, S. I. (2018) · ACS Nano · doi:10.1021/acsnano.7b08122 · Cited by 59
Gonzalez‐Molina, J., Moyano‐Galceran, L., Single, A., Gultekin, O., Alsalhi, S., & Lehti, K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.012 · Cited by 59
Zwald, F. O., Leitenberger, J. J., Zeitouni, N. C., Soon, S. L., Brewer, J. R., Arron, S. T., Bordeaux, J. S., Chung, C., Abdelmalek, M., Billingsley, E. M., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13593 · Cited by 58
Zhang, X., Men, K., Zhang, Y., Zhang, R., Yang, L., & Duan, X. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198747 · Cited by 58
Au, K. M., Wang, A. Z., & Park, S. I. (2020) · Science Advances · doi:10.1126/sciadv.aaz9798 · Cited by 58
Bagherifar, R., Kiaie, S. H., Hatami, Z., Ahmadi, A., Sadeghnejad, A., Baradaran, B., Jafari, R., & Javadzadeh, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00861-0 · Cited by 58
Zhao, Q., Jiang, D., Sun, X., Mo, Q., Chen, S., Chen, W., Gui, R., & Ma, X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00922-4 · Cited by 58
Zheng, B., Chen, H., Zhao, P., Pan, H., Wu, X., Gong, X., Wang, H., & Chang, J. K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b07642 · Cited by 57
Self-citationLei, Y., Qiao, Z., Tang, J., He, X., Shi, H., Ye, X., Yan, L., He, D., & Wang, K. (2018) · Theranostics · doi:10.7150/thno.24683 · Cited by 57
Self-citationMoro, M., Paolo, D. D., Milione, M., Centonze, G., Bornaghi, V., Borzi, C., Gandellini, P., Perri, P., Pastorino, U., Ponzoni, M., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.006 · Cited by 57
Jing, B., Qian, R., Jiang, D., Gai, Y., Liu, Z., Guo, F., Ren, S., Gao, Y., Lan, X., & An, R. F. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00888-3 · Cited by 57
Bae, J. E., Parayath, N. N., Ma, W., Amiji, M. M., Munshi, N. C., & Anderson, K. C. (2019) · Leukemia · doi:10.1038/s41375-019-0540-7 · Cited by 56
Luo, K., Guo, W., Yu, Y., Xu, S., Zhou, M., Xiang, K., Niu, K., Zhu, X., Zhu, G., An, Z., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.005 · Cited by 56
Zhang, P., Li, Z., Cao, W., Tang, J., Xia, Y., Peng, L., & Ma, J. (2023) · Advanced Materials · doi:10.1002/adma.202305215 · Cited by 56
Marano, F., Frairia, R., Rinella, L., Argenziano, M., Bussolati, B., Grange, C., Mastrocola, R., Castellano, I., Berta, L., Cavalli, R., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0045 · Cited by 55
Li, F., Li, T., Zhi, D., Xu, P., Wang, W., Hu, Y., Zhang, Y., Wang, S., Matula Thomas, J., Beauchamp Norman, J., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120219 · Cited by 55
Tesch, M. E., & Gelmon, K. A. (2020) · Drugs · doi:10.1007/s40265-020-01411-y · Cited by 55
Construction of nanomaterials as contrast agents or probes for glioma imaging
Zhao, W., Yu, X., Peng, S., Luo, Y., Li, J., & Lu, L. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00866-9 · Cited by 55
Advances in amphiphilic polylactide/vinyl polymer based nano-assemblies for drug delivery
Gigmès, D., & Trimaille, T. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102483 · Cited by 55
Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity
Chen, X., Momin, A., Wanggou, S., Wang, X., Min, H.-K., Dou, W., Gong, Z., Chan, J., Dong, W., Fan, J. J., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.007 · Cited by 55
Li, J., Wang, Q., Han, Y., Jiang, L., Lu, S., Wang, B., Qian, W., Zhu, M., Huang, H., & Qian, P. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01460-2 · Cited by 55
Self-citationActivation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
Naumann, K., Wehner, R., Schwarze, A., Petzold, C., Schmitz, M., & Rohayem, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/283649 · Cited by 54
Wang, L., Yang, D., Lv, J., Yu, D., & Xin, S.-J. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s131012 · Cited by 54
Vinhas, R., Fernandes, A. R., & Baptista, P. V. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.05.003 · Cited by 54
He, W., Yan, J., Sui, F., Wang, S., Su, X., Qu, Y., Yang, Q., Guo, H., Ji, M., Lu, W., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b07079 · Cited by 54
Wang, L., Xu, J., Yan, Y., Liu, H., & Li, F. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1593852 · Cited by 54
Self-citationChoi, B., Jung, H., Yu, B., Choi, H., Lee, J., & Kim, D. (2019) · Small · doi:10.1002/smll.201904378 · Cited by 54
Concepts in glioma immunotherapy
Platten, M., Bunse, L., Wick, W., & Bunse, T. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1874-x · Cited by 53
Singh, B., Jang, Y., Maharjan, S., Kim, H.-J., Lee, A. Y., Kim, S., Gankhuyag, N., Yang, M., Choi, Y., Cho, M., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.040 · Cited by 53
Wu, L., Wen, X., Wang, X., Wang, C., Sun, X., Wang, K., Zhang, H., Williams, T. A., Stacy, A. J., Chen, J., et al. (2017) · Theranostics · doi:10.7150/thno.21466 · Cited by 53
Self-citationSelf‐Assembled Aptamer‐Nanomedicine for Targeted Chemotherapy and Gene Therapy
Zhao, N., Zeng, Z., & Zu, Y. (2017) · Small · doi:10.1002/smll.201702103 · Cited by 53
Glioma targeting peptide modified apoferritin nanocage
Zhai, M., Wang, Y., Zhang, L., Liang, M., Fu, S., Cui, L., Yang, M., Gong, W., Li, Z., Lian, Y., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1464082 · Cited by 53
Therapeutic breakthroughs for metastatic thyroid cancer
Tiedje, V., & Fagin, J. A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0307-2 · Cited by 53
Shi, M., Zhang, J., Huang, Z., Chen, Y., Pan, S., Hu, H., Qiao, M., Chen, D., & Zhao, X. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02764e · Cited by 53
Kannan, R. M., Pitha, I., & Parikh, K. S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115005 · Cited by 53
Kinoshita, R., Ishima, Y., Ikeda-Imafuku, M., Kragh‐Hansen, U., Fang, J. Q., Nakamura, H., Chuang, V. T. G., Tanaka, R., Maeda, H., Kodama, A., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.036 · Cited by 52
Shi, L., Wang, X., Tu, Q., Wang, H., Zhang, H., Wang, P., Zhang, L., Huang, Z. W., Wang, X., Zhao, F., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s71245 · Cited by 52
Self-citationMartella, E., Ferroni, C., Guerrini, A., Ballestri, M., Columbaro, M., Santi, S., Sotgiu, G., Serra, M., Donati, D. M., Lucarelli, E., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113670 · Cited by 52
Varès, G., Jallet, V., Matsumoto, Y., Rentier, C., Takayama, K., Sasaki, T., Hayashi, Y., Kumada, H., & Sugawara, H. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102195 · Cited by 52
Yuan, Z.-Q., Chen, W.-L., You, B., Liu, Y., Yang, S.-D., Li, J., Zhu, W.-J., Zhou, X., Liu, C., & Zhang, X. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.025 · Cited by 51
Exosomes in cancer: Small transporters with big functions
Li, X., Wang, Y., Wang, Q., Liu, Y., Bao, W., & Wu, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.037 · Cited by 51
Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer
Jiang, H., Guo, Y., Yu, Z., Hu, P., & Shi, J. (2022) · National Science Review · doi:10.1093/nsr/nwac169 · Cited by 51
Lee, L. J., Yang, Z., Rahman, M. A., Ma, J., Kwak, K. J., McElroy, J., Shilo, K., Goparaju, C. M. V., Yu, L., Rom, W. N., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2129le · Cited by 50
Self-citationPeng, Y., Zhu, X., & Qiu, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.001 · Cited by 50
Nanoparticles for local delivery of siRNA in lung therapy
Kubczak, M., Michlewska, S., Bryszewska, M. J., Aigner, A. M., & Йонов, М. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114038 · Cited by 50
Choi, G., Kim, E., Park, E., & Lee, J. H. (2016) · Talanta · doi:10.1016/j.talanta.2016.09.061 · Cited by 49
Computational studies of micellar and nanoparticle nanomedicines
Sen, S., Han, Y., Rehak, P. L., Vuković, L., & Král, P. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00022k · Cited by 49
Wang, L., Lin, H., Chi, X., Sun, C., Huang, J., Tang, X., Chen, H., Luo, X., Yin, Z., & Gao, J. (2018) · Small · doi:10.1002/smll.201801612 · Cited by 49
Yang, Y., Meng, Y., Ye, J., Xia, X., Wang, H., Li, L., Dong, W., Jin, D., & Liu, Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.028 · Cited by 49
Self-citationLee, K. J., Ko, E. J., Park, Y., Park, S. S., Ju, E. J., Park, J. H., Shin, S. H., Suh, Y., Hong, S., Park, I. J., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120151 · Cited by 49
Su, X., Zhang, X., Liu, W., Yang, X., An, N., Yang, F., Sun, J., Xing, Y., & Shang, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.003 · Cited by 49
Xiao, Q., Li, X., Liu, C., Jiang, Y., He, Y., Zhang, W., Azevedo, H. S., Wu, W., Xia, Y., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.012 · Cited by 49
Shoyele, S., Maher, C. M., Lakshmikuttyamma, A., & Perepelyuk, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110488 · Cited by 48
Nagesh, P. K. B., Chowdhury, P., Hatami, E., Kumari, S., Kashyap, V. K., Tripathi, M. K., Wagh, S., Meibohm, B., Chauhan, S. C., Jaggi, M., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14738 · Cited by 48
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Lumish, M. A., Falchi, L., Imber, B. S., Scordo, M., von Keudell, G., & Joffe, E. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01018-6 · Cited by 48
A Focus on “Bio” in Bio–Nanoscience: The Impact of Biological Factors on Nanomaterial Interactions
Cortez‐Jugo, C., Czuba‐Wojnilowicz, E., Tan, A. E. Q., & Caruso, F. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100574 · Cited by 48
Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes
Shalhout, S. Z., Kaufman, H. L., Emerick, K. S., & Miller, D. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2971 · Cited by 48
An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy
Liu, M., Li, Z. H., Xu, F., Lai, L., Wang, Q. Q., Tang, G., & Yang, W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.082 · Cited by 47
González-Fernández, Y., Imbuluzqueta, E., Zalacaín, M., Mollinedo, F., Patiño‐García, A., & Blanco‐Prieto, M. J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.012 · Cited by 47
Sun, Y., Miao, H., Ma, S., Zhang, L., You, C., Tang, F., Cui, Y., Tian, X., Wang, F., Luo, Y. M., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.024 · Cited by 47
Self-citationLiu, X., Li, Y., Sun, X., Muftuoglu, Y., Wang, B., Yu, T., Hu, Y., Ma, L., Xiang, M., Guo, G. F., et al. (2018) · Theranostics · doi:10.7150/thno.24157 · Cited by 47
Self-citationCarbon dots stabilized silver–lipid nano hybrids for sensitive label free DNA detection
Divya, K. P., Karthikeyan, R., Sinduja, B., Grace, A. A., John, S. A., Hahn, J. H., & Dharuman, V. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.03.027 · Cited by 47
Tyrosine Kinase Inhibitor Gold Nanoconjugates for the Treatment of Non-Small Cell Lung Cancer
Cryer, A. M., Chan, C. H., Eftychidou, A., Maksoudian, C., Mahesh, M., Tetley, T. D., Spivey, A. C., & Thorley, A. J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b02986 · Cited by 47
Tumor-targeted nano-delivery system of therapeutic RNA
Wang, M., Zhao, J., Jiang, H., & Wang, X. (2022) · Materials Horizons · doi:10.1039/d1mh01969d · Cited by 47
Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment
Sia, C. S., Lim, H. P., Tey, B. T., Goh, B. H., & Low, L. E. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188779 · Cited by 47
The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies
MacKinnon, A. C., Kopatz, J., & Sethi, T. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq023 · Cited by 46
Jazi, K. K., Münch, P., Alexander, A. A., Fischer, M. D., Pfleiderer, K., Piechutta, M., Karreman, M. A., Solecki, G. M., Berghoff, A. S., Friedrich, M., et al. (2020) · Theranostics · doi:10.7150/thno.38659 · Cited by 46
Song, J., Ju, Y., Amarasena, T. H., Lin, Z., Mettu, S., Zhou, J., Rahim, M. A., Ang, C., Cortez‐Jugo, C., Kent, S. J., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c01642 · Cited by 46
Cui, X., Liang, Z., Lu, J., Wang, X., Jia, F., Hu, Q., Xiao, X., Deng, X., Wu, Y. F., & Sheng, W. (2021) · Nanoscale · doi:10.1039/d1nr03161a · Cited by 46
Ji, G., Si, X., Dong, S., Xu, Y., Li, M., Yang, B., Tang, Z., Fang, X., Huang, L., Song, W., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01360 · Cited by 46
Self-citationCancer phototherapy with nano-bacteria biohybrids
Lu, H., Niu, L., Yu, L., Jin, K., Zhang, J., Liu, J., Zhu, X., Wu, Y., & Zhang, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.009 · Cited by 46
Roy, A., Zhao, Y., Yang, Y., Szeitz, A. J., Klassen, T., & Li, S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.019 · Cited by 45
Guo, D., Shi, C., Wang, X., Wang, L., Zhang, S., & Luo, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.041 · Cited by 45
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy
Wang, F., Pang, J., Huang, L., Wang, R., Li, D., Sun, K., Wang, L., & Zhang, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s147747 · Cited by 45
X-rays-optimized delivery of radiolabeled albumin for cancer theranostics
Yi, X., Zhou, H., Zhang, Z., Xiong, S., & Yang, K. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119764 · Cited by 45
Targeted nanomedicines for the treatment of bone disease and regeneration
Ordikhani, F., Zandi, N., Mazaheri, M., Luther, G. A., Ghovvati, M., Akbarzadeh, A., & Annabi, N. (2020) · Medicinal Research Reviews · doi:10.1002/med.21759 · Cited by 45
Chen, Y., Zeng, L., Zhu, H., Wu, Q., Liu, R., Liang, Q. Y., Chen, B., Dai, H., Tang, K., Liao, C., et al. (2022) · Small Methods · doi:10.1002/smtd.202201086 · Cited by 45
Wang, Y., Wu, Y., Li, L., Ma, C., Zhang, S., Lin, S., Zhang, L. W., Wang, Y., & Gao, M. (2023) · ACS Nano · doi:10.1021/acsnano.2c09685 · Cited by 45
Drug-dendrimer complexes and conjugates: Detailed furtherance through theory and experiments
Sathe, R. Y., & Bharatam, P. V. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102639 · Cited by 44
Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma
Guo, X., Sui, R., & Piao, H. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01584-6 · Cited by 44
Hsp70‐Targeting and Size‐Tunable Nanoparticles Combine with PD‐1 Checkpoint Blockade to Treat Glioma
Xie, R., Wang, Y., Tong, F., Yang, W., Lei, T., Du, Y., Wang, X., Yang, Z., Gong, T., Shevtsov, M. A., et al. (2023) · Small · doi:10.1002/smll.202300570 · Cited by 44
Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection
Wang, X., Gu, M., Toh, T. B., Abdullah, N. L. B., & Chow, E. K. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317735497 · Cited by 43
Zhao, Q., Li, J., Wu, B., Shang, Y., Huang, X., Dong, H., Liu, H., Chen, W., Gui, R., & Nie, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c05763 · Cited by 43
Application of phototherapeutic-based nanoparticles in colorectal cancer
Yan, J., Wang, C., Jiang, X., Wei, Y., Wang, Q., Cui, K., Xu, X. L., Wang, F., & Zhang, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58773 · Cited by 43
Surface-enhanced Raman scattering biosensors for detection of oncomiRs in breast cancer
Chauhan, P., Bhargava, A., Kumari, R., Ratre, P., Tiwari, R. R., Srivastava, R. K., Goryacheva, I. Y., & Mishra, P. K. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.04.016 · Cited by 43
Yang, Y., Hu, Y., Du, H., Ren, L., & Wang, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s156347 · Cited by 42
Self-citationNanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines
Beg, S., Kawish, S. M., Panda, S. K., Tarique, M., Malik, A., Afaq, S., AlSamghan, A. S., Iqbal, J., Alam, K., & Rahman, M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.005 · Cited by 42
Israel, L. L., Galstyan, A., Cox, A., Shatalova, E. S., Sun, T., Rashid, M.-H., Grodzinski, Z., Chiechi, A., Fuchs, D.-T., Patil, R., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c10034 · Cited by 41
Villadolid, J. J., Ersek, J. L., Fong, M. K., Sirianno, L., & Story, E. S. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2015.10.01 · Cited by 41
Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma
Tang, R., Zheleznyak, A., Mixdorf, M., Ghai, A., Prior, J. L., Black, K. C. L., Shokeen, M., Reed, N., Biswas, P., & Achilefu, S. A. (2020) · ACS Nano · doi:10.1021/acsnano.9b09618 · Cited by 41
Sharma, A. K., Arya, A., Sahoo, P. K., & MAJUMDAR, D. K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.05.060 · Cited by 40
Etrych, T., Daumová, L., Pokorná, E., Tušková, D., Lidický, O., Kolářová, V., Pankrác, J., Šefc, L., Chytil, P., & Klener, P. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.018 · Cited by 40
Liu, Y., Wang, R., Hou, J., Sun, B., Zhu, B., Qiao, Z., Su, Y., & Zhu, X. (2018) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00501 · Cited by 40
Liang, B., Zuo, D., Yu, K., Cai, X., Qiao, B., Deng, R., Yang, J.-S., Chu, L., Deng, Z., Zheng, Y., et al. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110460 · Cited by 40
Hou, G., Qian, J., Guo, M., Xu, W., Wang, J., Wang, Y., & Suo, A. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118810 · Cited by 40
Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors
Ahmad, A., Rashid, S., Chaudhary, A. A., Alawam, A. S., Alghonaim, M. I., Raza, S. S., & Khan, R. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.002 · Cited by 40
Luo, L., Zhang, B., Tao, F., Chen, Z., Ye, Q., Zhao, X., & Wu, J. (2023) · ACS Nano · doi:10.1021/acsnano.3c00295 · Cited by 40
Srivastava, P., Hira, S. K., Srivastava, D. N., Singh, V., Gupta, U., Singh, R. K., Singh, R., & Manna, P. P. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18729 · Cited by 39
Huang, Y.-H., Vakili, M. R., Molavi, O., Morrissey, Y. C., Wu, C., de Paiva, I. M., Soleimani, A. H., Sanaee, F., Lavasanifar, A., & Lai, R. L. (2019) · Cancers · doi:10.3390/cancers11020248 · Cited by 39
Emerging trends in the application of gold nanoformulations in colon cancer diagnosis and treatment
Aldahhan, R., Almohazey, D., & Khan, F. A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.008 · Cited by 39
Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Qiu, Q., Ding, X., Chen, J., Chen, S., & Wang, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.016 · Cited by 39
Self-citationAu, K. M., Balhorn, R., Balhorn, M. C., Park, S. I., & Wang, A. Z. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00746 · Cited by 38
Omer, W. E., El-Kemary, M. A., Elsaady, M. M., Abou-Omar, M. N., Youssef, A. O., Sayqal, A. A., Gouda, A. A., & Attia, M. S. (2020) · ACS Omega · doi:10.1021/acsomega.9b02833 · Cited by 38
Sun, Y., Xie, Y., Tang, H., Ren, Z., Luan, X., Zhang, Y., Zhu, M. J., Lv, Z., Bao, H., Li, Y., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s340180 · Cited by 38
Novel strategies in melanoma treatment using silver nanoparticles
Zhao, J., Gao, N., Xu, J., Zhu, X., Ling, G., & Zhang, P. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216148 · Cited by 38
Self-citationNevins, S., McLoughlin, C. D., Oliveros, A., Stein, J. B., Rashid, M. A., Hou, Y., Jang, M., & Lee, K. (2023) · Small · doi:10.1002/smll.202300744 · Cited by 38
Gasparri, A. M., Sacchi, A., Basso, V., Cortesi, F., Freschi, M., Rrapaj, E., Bellone, M., Casorati, G., Dellabona, P., Mondino, A., et al. (2019) · Small · doi:10.1002/smll.201903462 · Cited by 37
Jordan, M., & Waxman, D. J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.029 · Cited by 37
Bai, Y., Wang, Y., Zhang, X., Fu, J., Xing, X., Wang, C., Gao, L., Liu, Y., & Shi, L. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118636 · Cited by 37
Gu, W., Zhang, T., Gao, J., Wang, Y., Li, D., Zhao, Z., Jiang, B., Dong, Z., & Liu, H. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1662513 · Cited by 37
Nigro, A., Frattaruolo, L., Fava, M., Napoli, I. D., Greco, M., Comandé, A., Santo, M. D., PELLEGRINO, M. A., Ricci, E. D., Giordano, F., et al. (2020) · Cancers · doi:10.3390/cancers12092709 · Cited by 37
Turchan, W. T., Pitroda, S. P., & Weichselbaum, R. R. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0145 · Cited by 37
Polymeric nanomedicines targeting hematological malignancies
Gu, W., Qu, R., Meng, F., Cornelissen, J. J. L. M., & Zhong, Z. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.001 · Cited by 37
Liu, C., Tang, C., & Yin, C. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119097 · Cited by 37
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Hu, X., Zhu, H., He, X., Chen, J., Xiong, L., Shen, Y., Li, J., Xu, Y., Chen, W., Liu, X., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.051 · Cited by 37
Self-citationRecent Developments in Nanoparticle‐Based Photo‐Immunotherapy for Cancer Treatment
Guo, Z., Zhu, A. T., Fang, R. H., & Zhang, L. (2023) · Small Methods · doi:10.1002/smtd.202300252 · Cited by 37
Enhanced shRNA Delivery and ABCG2 Silencing by Charge-Reversible Layered Nanocarriers
Chen, Z., Zhang, L., He, Y., Shen, Y., & Li, Y. (2014) · Small · doi:10.1002/smll.201401397 · Cited by 36
Mauro, P. P. D., Cascante, A., Brugada-Vilà, P., Gómez‐Vallejo, V., Llop, J., & Borrós, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.022 · Cited by 36
Akhter, M. H., Rizwanullah, M., Ahmad, J., Amin, S., Ahmad, M. Z., Minhaj, M. A., Mujtaba, M. A., & Ali, J. (2020) · Drug Research · doi:10.1055/a-1296-7870 · Cited by 36
Yu, Y., Shen, X., Xiao, X. H., Li, L., & Huang, Y. (2023) · Small · doi:10.1002/smll.202301149 · Cited by 36
Park, G., Son, B., Kang, J., Lee, S., Jeon, J., Kim, J.-H., Yi, G., Youn, H., Moon, C., Nam, S. Y., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.015 · Cited by 35
Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma
Meng, X., Zhang, H., Zhang, M., Wang, B., Liu, Y., Wang, Y., Fang, X., Zhang, J., Yao, Z., & Bu, W. (2019) · Advanced Science · doi:10.1002/advs.201901214 · Cited by 35
Self-citationDrug delivery approaches for HuR-targeted therapy for lung cancer
Raguraman, R., Shanmugarama, S., Mehta, M., Peterson, J. E. G., Zhao, Y. D., Munshi, A., & Ramesh, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114068 · Cited by 35
Liu, L., Qi, X.-J., Zhong, Z., & Zhang, E.-N. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.001 · Cited by 34
Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis
Mitchell, M. J., Webster, J., Chung, A., Guimarães, P. P. G., Khan, O. F., & Langer, R. (2017) · Nature Communications · doi:10.1038/ncomms14179 · Cited by 34
Cervello, M., Pitarresi, G. L., Volpe, A. B., Porsio, B., Balasus, D., Emma, M. R., Azzolina, A., Puleio, R., Loria, G. R., Puleo, S., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.014 · Cited by 34
Li, H., Wang, P., Gong, W., Wang, Q., Zhou, J., Zhu, W., & Cheng, Y. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700912 · Cited by 34
Self-citationDetappe, A., Reidy, M., Yu, Y., Mathieu, C., Nguyen, H. V. ‐., Coroller, T. P., Lam, F. C., Jarolím, P., Harvey, P., Protti, A., et al. (2019) · Nanoscale · doi:10.1039/c9nr06512a · Cited by 34
Yu, T., Tong, L., Ao, Y., Zhang, G., Liu, Y., & Zhang, H. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111534 · Cited by 33
Advances in Topical Treatments of Cutaneous Malignancies
Algarin, Y. A., Jambusaria‐Pahlajani, A., Ruiz, E. S., & Patel, V. A. (2022) · American Journal of Clinical Dermatology · doi:10.1007/s40257-022-00731-x · Cited by 33
Li, S., Zhang, D., Sheng, S., & Sun, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137335 · Cited by 32
Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system
Li, S., Liu, Y., Rui, Y., Tang, L., Achilefu, S. A., & Gu, Y. (2018) · Theranostics · doi:10.7150/thno.24469 · Cited by 32
González-Fernández, Y., Brown, H. K., Patiño‐García, A., Heymann, D., & Blanco‐Prieto, M. J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.030 · Cited by 32
Yang, L., & Zeng, C. (2018) · Molecules · doi:10.3390/molecules23123122 · Cited by 32
Pereira‐Silva, M., Alvarez‐Lorenzo, C., Concheiro, Á., Paiva‐Santos, A. C., Veiga, F., & Figueiras, A. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.10.013 · Cited by 32
On, K. C., Rho, J., Yoon, H. Y., Chang, H., Yhee, J. Y., Yoon, J. S., Jeong, S. Y., Kim, H. K., & Kim, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070621 · Cited by 32
Cardiovascular Outcomes in Thyroid Cancer Patients Treated With Thyroidectomy: A Meta-Analysis
Lee, E. K., Ahn, H. Y., Ku, E. J., Yoo, W. S., Lee, Y. K., Nam, K., Chai, Y. J., Moon, S., & Jung, Y. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab576 · Cited by 32
Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis
Suman, S., & Markovic, S. N. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.07.002 · Cited by 32
Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery
Haghighi, F. H., Binaymotlagh, R., Fratoddi, I., Chronopoulou, L., & Palocci, C. (2023) · Gels · doi:10.3390/gels9120953 · Cited by 32
Polymeric Nanohydrogel in Topical Drug Delivery System
Yuniarsih, N., Chaerunisaa, A. Y., Elamin, K. M., & Wathoni, N. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442123 · Cited by 32
Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance After Surgery
Weinberg, D. S., Pickhardt, P. J., Bruining, D. H., Edwards, K. W., Fletcher, J. G., Gollub, M. J., Keenan, E., Kupfer, S. S., Li, T., Lubner, S. J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.11.025 · Cited by 31
Enhancing Prostate‐Cancer‐Specific MRI by Genetic Amplified Nanoparticle Tumor Homing
Zhao, Y., Peng, J., Yang, J., Zhang, E., Huang, L. F., Yang, H. W., Kakadiaris, E., Li, J., Yan, B., Shang, Z., et al. (2019) · Advanced Materials · doi:10.1002/adma.201900928 · Cited by 31
Exploiting nanoscale cooperativity for precision medicine
Wilhelm, J., Wang, Z., Sumer, B. D., & Gao, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.012 · Cited by 31
Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics
Paramanantham, A., Asfiya, R., Das, S., McCully, G., & Srivastava, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113637 · Cited by 31
Xu, Z., Wang, Y., Han, J., Xu, Q., Ren, J., Xu, J., Wang, Y., & Chai, Z. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04925 · Cited by 30
Self-citationA Novel Laser Fiberscope for Simultaneous Imaging and Phototherapy of Peripheral Lung Cancer
Kinoshita, T., Effat, A., Gregor, A., Inage, T., Ishiwata, T., Motooka, Y., Ujiie, H., Wilson, B. C., Zheng, G., Weersink, R., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.04.010 · Cited by 30
Tiwari, R. K., Singh, S., Gupta, C. L., Pandey, P., Singh, V. K., Sayyed, U., Shekh, R., & Bajpai, P. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1750393 · Cited by 30
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review
Marshall, D. C., Tarras, E. S., Ali, A. S., Bloom, J. R., Torres, M. A., & Kahn, J. M. (2022) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21726 · Cited by 30
Impact of Nanomedicine in Women's Metastatic Breast Cancer
Ashkarran, A. A., Lin, Z., Rana, J., Bumpers, H. L., Sempere, L. F., & Mahmoudi, M. (2023) · Small · doi:10.1002/smll.202301385 · Cited by 30
Oral delivery of shRNA based on amino acid modified chitosan for improved antitumor efficacy
Zheng, H., Tang, C., & Yin, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.024 · Cited by 29
Karinaga, R., Anada, T., Minari, J., Mizu, M., Koumoto, K., Fukuda, J., Nakazawa, K., Hasegawa, T., Numata, M., Shinkai, S., et al. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.08.023 · Cited by 29
Kim, J., Minai‐Tehrani, A., Kim, Y.-K., Shin, J., Hong, S., Kim, H.-J., Lee, H.-D., Chang, S.-H., Yu, K., Bang, Y., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.024 · Cited by 29
Hong, C. A., Cho, S. K., Edson, J. A., Kim, J., Ingato, D., Pham, B., Chuang, A., Fruman, D. A., & Kwon, Y. J. (2016) · ACS Nano · doi:10.1021/acsnano.6b04155 · Cited by 29
Advancements in Nanomedicine for Multiple Myeloma
Detappe, A., Bustoros, M. W., Mouhieddine, T. H., & Ghoroghchian, P. P. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.005 · Cited by 29
Zhang, X. Y., Shen, Y., Li, J., & Chen, G. (2019) · Medicine · doi:10.1097/md.0000000000016935 · Cited by 29
Zaritski, A., Castillo‐Ecija, H., Kumarasamy, M., Peled, E., Arzi, R. S., Carcaboso, A. M., & Sosnik, A. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12682 · Cited by 29
Wang, B., Wang, F., Ding, A., Zhao, H., & Bu, X. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02283-9 · Cited by 29
Self-citationBoto, C., Quartin, E., Cai, Y., Martín-Lorenzo, A., Cenador, M. B. G., Pinto, S., Gupta, R., Enver, T., Sánchez-García, I., Hong, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15204 · Cited by 28
Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo
Suffian, I. F. M., Wang, J. T.-W., Hodgins, N. O., Klippstein, R., Garcia‐Maya, M., Brown, P. R., Nishimura, Y., Heidari, H., Bals, S., Sosabowski, J. K., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.012 · Cited by 28
Liu, Y., Li, L., Yu, J., et al. (2018) · Cancer Biomarkers · doi:10.3233/cbm-181386 · Cited by 28
Agarwal, S., Muniyandi, P., Maekawa, T., & Kumar, D. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.033 · Cited by 28
Zilkowski, I., Ziouti, F., Schulze, A., Hauck, S. M., Schmidt, S., Mainz, L., Sauer, M., Albrecht, K., Jundt, F., & Gröll, J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01553 · Cited by 28
Srivastava, P., Hira, S. K., Paladhi, A., Singh, R. K., Gupta, U., Srivastava, D. N., Singh, R., & Manna, P. P. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02628b · Cited by 28
Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics
Park, M.-C., Vaikari, V. P., Lam, A. T., Zhang, Y., MacKay, J. A., & Alachkar, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.021 · Cited by 28
Metal coordination micelles for anti-cancer treatment by gene-editing and phototherapy
Zhang, C., Wang, X., Liu, G., Ren, H., Li, J., Jiang, Z., Liu, J., Lovell, J. F., & Zhang, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.042 · Cited by 28
Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer
Kitsios, K., Sharifi, S., & Mahmoudi, M. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00044 · Cited by 28
Chen, J., Sun, Y., Chen, Q., Wang, L., Wang, S. H., Tang, Y., Shi, X., & Wang, H. (2016) · Nanoscale · doi:10.1039/c6nr03143a · Cited by 27
Self-citationPrecision targeted therapy for EGFR mutation‐positive NSCLC : Dilemmas and coping strategies
Meng, Y., Bai, R., & Cui, J. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.14858 · Cited by 27
Applications of Nanoparticles for Brain Cancer Imaging and Therapy
Zhang, L., & Zhao, D. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1896 · Cited by 26
Yin, F., Wang, Z., Jiang, Y., Zhang, T., Wang, Z., Hua, Y., Song, Z., Liu, J., Xu, W., Xu, J., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102085 · Cited by 26
Self-citationPoudel, K., Park, S. J., Hwang, J., Ku, S., Yong, C. S., Kim, J. O., & Byeon, J. H. (2020) · ACS Nano · doi:10.1021/acsnano.9b09731 · Cited by 26
IL-11Rα-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma
Jiang, J., Wang, R., Yang, L., Sha, Y., Zhao, S., Guo, J., Chen, D., Zhong, Z., & Meng, F. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.048 · Cited by 26
In vitro controlled release of cisplatin from gold-carbon nanobottles via cleavable linkages
Pastorin, G., Li, J., Yoong, S. L., Goh, W. J., Czarny, B., Yang, Z. H., Poddar, K., Dykas, M. M., Patra, A., Venkatesan, T., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93810 · Cited by 25
Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma
Ackley, J. C., Ochoa, M. A., Ghoshal, D., Roy, K., Lonial, S., & Boise, L. (2021) · Cancers · doi:10.3390/cancers13194787 · Cited by 25
Chemoimmunological Cascade Cancer Therapy Using Fluorine Assembly Nanomedicine
Zhang, Q., Wu, P., Wu, J., Shou, H., Ming, X., Wang, S., & Wang, B. (2023) · ACS Nano · doi:10.1021/acsnano.2c12600 · Cited by 25
Self-citationNaumann, J. A., Widen, J. C., Jonart, L. A., Ebadi, M., Tang, J. H., Gordon, D. J., Harki, D. A., & Gordon, P. M. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00774 · Cited by 24
Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma
Knapp, C. M., He, J., LISTER, J. W., & Whitehead, K. A. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10088 · Cited by 24
Feng, Y., Chen, H., Shao, B., Zhao, S., Wang, Z., & You, H. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b07129 · Cited by 24
Le‐Rademacher, J. G., Dahlberg, S. E., Lee, J. J., Adjei, A. A., & Mandrekar, S. J. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.08.2019 · Cited by 24
Gu, X., Zhu, Z., Fan, Q., Wei, Y., Wang, G., Meng, F., Zhong, Z., & Deng, C. (2019) · Small · doi:10.1002/smll.201902577 · Cited by 24
A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics
Wang, Q., Sui, G., Wu, X., Teng, D., Zhu, L., Guan, S., Ran, H., Wang, Z., & Wang, H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.043 · Cited by 24
Self-citationNew Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Kozyra, P., Krasowska, D., & Pitucha, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116084 · Cited by 24
HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia
Shen, N., Yan, F., Pang, J., Gao, Z., Al‐Kali, A., Haynes, C. L., Litzow, M. R., & Liu, S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b01696 · Cited by 23
Xiao, K., Liu, Q., Awwad, N. A., Zhang, H., Lai, L. F., Luo, Y., Lee, J. S., Li, Y., & Lam, K. S. (2018) · Nanoscale · doi:10.1039/c8nr00680f · Cited by 23
Stefanick, J. F., Omstead, D. T., Ashley, J. D., Deak, P., Mustafaoğlu, N., Kiziltepe, T., & Bilgiçer, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.033 · Cited by 23
Luo, T., Jiang, M., Cheng, Z., Lin, Y., Chen, Y., Zhang, Z., Zhou, J., Zhou, W., Yu, X., Li, S., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01961-9 · Cited by 23
Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy
Bao, C., Duan, J., Xie, Y., Feng, X.-P., Cui, W., Chen, S., Li, P., Liu, Y., Wang, J., Wang, G., et al. (2023) · Nano-Micro Letters · doi:10.1007/s40820-023-01153-y · Cited by 23
Faruque, H. A., Choi, E., Lee, H., Kim, J., Park, S., & Kim, E. (2020) · Nanoscale · doi:10.1039/c9nr06730b · Cited by 22
Wu, Y., Li, H., Yan, Y., Wang, K., Cheng, Y., Li, Y., Zhu, X., Xie, J., & Sun, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s244172 · Cited by 21
Self-citationFuture Prospects for Clinical Applications of Nanocarbons Focusing on Carbon Nanotubes
Saito, N., Haniu, H., Aoki, K., Nishimura, N., & Uemura, T. (2022) · Advanced Science · doi:10.1002/advs.202201214 · Cited by 21
WINDOW consortium: A path towards increased therapy efficacy against glioblastoma
Abdul, K., Houweling, M., Svensson, F., Narayan, R. S., Cornelissen, F. M. G., Küçükosmanoğlu, A., Metzakopian, E., Watts, C., Bailey, D. S., Würdinger, T., et al. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.10.001 · Cited by 20
Cited by
Exploring and bypassing resistance to targeted therapies in colorectal cancer
Favier, S., Xiong, W., Chalabi-Dchar, M., Chettab, K., Piercey, O., Wu, T., Fenouil, T., Albaret, M.-A., Jordheim, L. P., Diaz, J.-J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118741 · Cited by 12
Tao, J., Ning, W., Lu, W., Wang, R., Zhou, H., Zhang, H., Xu, J., Wang, S., Teng, Z., & Wang, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.058 · Cited by 10
Self-citation
Metadata
- Authors
- Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-08-12
- Volume
- 9
- Issue
- 1
- Pages
- 200-200
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4401497204
- Cited by
- 558
- References
- 1,028
- FWCI
- 58.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.